PL393153A1 - Preparaty peptydowe oraz peptydy o działaniu przeciwnowotworowym - Google Patents

Preparaty peptydowe oraz peptydy o działaniu przeciwnowotworowym

Info

Publication number: PL393153A1
Authority: PL; Poland
Prior art keywords: components; peptides; peptide preparations; anticancer properties; oncological
Prior art date: 2010-12-06

Application number

PL393153A

Other languages

English (en)

Other versions

PL226806B1 (pl

Inventor

Andrzej W. Lipkowski

Sergiusz Markowicz

Original Assignee

Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-06

Filing date

2010-12-06

Publication date

2012-06-18

2010-12-06 Application filed by Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan filed Critical Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan

2010-12-06 Priority to PL393153A priority Critical patent/PL226806B1/pl

2011-12-06 Priority to US13/992,023 priority patent/US9365633B2/en

2011-12-06 Priority to EP11846061.7A priority patent/EP2649089A2/en

2011-12-06 Priority to PCT/PL2011/050049 priority patent/WO2012078060A2/en

2012-06-18 Publication of PL393153A1 publication Critical patent/PL393153A1/pl

2017-09-29 Publication of PL226806B1 publication Critical patent/PL226806B1/pl

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
238000002360 preparation method Methods 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
230000001093 anti-cancer Effects 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 2
210000004209 hair Anatomy 0.000 abstract 2
230000000771 oncological effect Effects 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
230000000259 anti-tumor effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000006862 enzymatic digestion Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1
210000002268 wool Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

PL393153A 2010-12-06 2010-12-06 Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym PL226806B1 (pl)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
PL393153A PL226806B1 (pl)	2010-12-06	2010-12-06	Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym
US13/992,023 US9365633B2 (en)	2010-12-06	2011-12-06	Peptide preparations and peptides with antitumour activity
EP11846061.7A EP2649089A2 (en)	2010-12-06	2011-12-06	Peptide preparations and peptides with antitumour activity
PCT/PL2011/050049 WO2012078060A2 (en)	2010-12-06	2011-12-06	Peptide preparations and peptides with antitumour activity

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL393153A PL226806B1 (pl)	2010-12-06	2010-12-06	Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym

Publications (2)

Publication Number	Publication Date
PL393153A1 true PL393153A1 (pl)	2012-06-18
PL226806B1 PL226806B1 (pl)	2017-09-29

Family

ID=46197672

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL393153A PL226806B1 (pl)	2010-12-06	2010-12-06	Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym

Country Status (4)

Country	Link
US (1)	US9365633B2 (pl)
EP (1)	EP2649089A2 (pl)
PL (1)	PL226806B1 (pl)
WO (1)	WO2012078060A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2018012935A1 (ko) *	2016-07-14	2018-01-18	경희대학교 산학협력단	케라틴을 포함하는 항암용 조성물
CN116041427B (zh) *	2022-11-18	2023-09-29	中国农业大学	两种杂粮来源的ace抑制肽及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5527773A (en)	1993-08-25	1996-06-18	United States Of America	Use of synthetic peptides to disrupt the cytoskeleton
PL179342B1 (pl)	1995-03-24	2000-08-31	Inst Chemii Przemyslowej Im Pr	Sposób aktywacji surowców keratynowych przed hydrolizą enzymatyczną do celów kosmetycznych
US20040006205A1 (en) *	2001-04-03	2004-01-08	Li Li	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1478328B1 (en)	2002-01-28	2013-06-05	Keraplast Technologies Ltd.	Bioactive keratin peptides
FR2883168B1 (fr) *	2005-03-18	2008-01-11	Oreal	Compositions cosmetiques de soin, renforcement et/ou reparation des substrats keratiniques comprenant des polypeptides kap

2010
- 2010-12-06 PL PL393153A patent/PL226806B1/pl unknown
2011
- 2011-12-06 WO PCT/PL2011/050049 patent/WO2012078060A2/en not_active Ceased
- 2011-12-06 EP EP11846061.7A patent/EP2649089A2/en not_active Withdrawn
- 2011-12-06 US US13/992,023 patent/US9365633B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20140315824A1 (en)	2014-10-23
US9365633B2 (en)	2016-06-14
WO2012078060A2 (en)	2012-06-14
EP2649089A2 (en)	2013-10-16
WO2012078060A3 (en)	2013-01-03
PL226806B1 (pl)	2017-09-29

Similar Documents

Publication	Publication Date	Title
NZ603901A (en)	2014-10-31	Vectors and sequences for the treatment of diseases
TN2014000319A1 (en)	2015-12-21	Imidazopyrrolidinone compounds
MY158992A (en)	2016-11-30	Forms of rifaximin and uses thereof
EA201370018A1 (ru)	2013-09-30	Составы рифаксимина и их применение
MX2020011675A (es)	2020-12-03	Peptidos novedosos y acidos nucleicos de los mismos contra tumores tal como los de cancer gastrico y gastrointestinal.
NI201400026A (es)	2015-01-13	3 - pirimidin - 4 - il - oxazolidin - 2 - onas como inhibidores de la idh mutante.
PH12013501892A1 (en)	2013-10-14	Nutritional compositions including branched chain fatty acids for wound healing
WO2013188813A3 (en)	2014-03-13	Novel therapeutics for brain cancer
PH12012501680A1 (en)	2012-11-05	Compositions and methods for the diagnosis and treatment of tumor
MX367970B (es)	2019-09-11	Tratamientos de combinación para melanoma que comprenden la administración de cobimetinib y vemurafinib.
EP4582090A3 (en)	2025-09-17	Composition comprising pegylated arginine deiminase
MX2013004061A (es)	2013-07-22	Analogos de ciclosporina.
GB201001602D0 (en)	2010-03-17	Oligopeptidic compounds and uses therof
NZ708016A (en)	2018-02-23	Lyophilized preparations of melphalan flufenamide
IN2014DN09228A (pl)	2015-07-10
PH12014500219A1 (en)	2014-03-17	Polyacrylate-based active compound-comprising particles
MX2013007995A (es)	2013-12-02	Peptidos derivados de lactoferrina humana y su uso.
WO2015081306A3 (en)	2015-11-19	Peptide tyrosinase activators
MX2013004062A (es)	2013-07-22	Analogos de ciclosporina.
MX2013012045A (es)	2014-05-27	Péptidos con actividad antimicrobiana, composiciones farmacéuticas para la profilaxis y el tratamiento de animales, composiciones para la profilaxis y el tratamiento de vegetales, usos de esos péptidos y usos del extracto de paenibacillus elgii ourofinensis.
PH12012501963A1 (en)	2013-01-07	Compositions and methods for the diagnosis and treatment of tumor
NZ631639A (en)	2016-09-30	Methods and compositions for treating and diagnosing acute myocardial infarction
PL393153A1 (pl)	2012-06-18	Preparaty peptydowe oraz peptydy o działaniu przeciwnowotworowym
EP2597949A4 (en)	2014-01-15	SUBMIKROMETERZUSAMMENSETZUNGEN
SG178967A1 (en)	2012-04-27	Antimicrobial compositions and products